Substituted diazaspiroalkanes as androgen receptor modulators
Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.
1. A capsule comprising a compound having a formula:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant.
2. The capsule of claim 1 , wherein the capsule is coated with gelatin, wax, shellac, or sugar, or a combination thereof.
3. The capsule of claim 1 , wherein the capsule comprises the compound having a formula:
4. The capsule of claim 1 , wherein the capsule comprises the compound having a formula:
5. The capsule of claim 1 , wherein the capsule comprises the compound having a formula:
in a range of from 0.0005 to 500 mg.
6. The capsule of claim 1 , wherein the capsule comprises the compound having a formula:
in a range of from 0.01 to 50 mg.
7. The capsule of claim 1 , wherein the capsule comprises the compound having a formula:
in a range of from 0.05 to 10 mg.
8. A tablet comprising a compound having a formula:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant.
9. The tablet of claim 8 , wherein the tablet is coated with gelatin, wax, shellac, or sugar, or a combination thereof.
10. The tablet of claim 8 , wherein the tablet comprises the compound having a formula:
11. The tablet of claim 8 , wherein the tablet comprises the compound having a formula:
12. The tablet of claim 8 , wherein the tablet comprises the compound having a formula:
in a range of from 0.0005 to 500 mg.
13. The tablet of claim 8 , wherein the tablet comprises the compound having a formula:
in a range of from 0.01 to 50 mg.
14. The tablet of claim 8 , wherein the tablet comprises the compound having a formula:
in a range of from 0.05 to 10 mg.
15. A pill comprising a compound having a formula:
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant.
16. The pill of claim 15 , wherein the pill is coated with gelatin, wax, shellac, or sugar, or a combination thereof.
17. The pill of claim 15 , wherein the pill comprises the compound having a formula:
18. The pill of claim 15 , wherein the pill comprises the compound having a formula:
19. The pill of claim 15 , wherein the pill comprises the compound having a formula:
in a range of from 0.0005 to 500 mg.
20. The pill of claim 15 , wherein the pill comprises the compound having a formula:
in a range of from 0.01 to 50 mg.
21. The pill of claim 15 , wherein the pill comprises the compound having a formula:
in a range of from 0.05 to 10 mg.